Talk:Octopamine (drug)
Latest comment: 4 years ago by BrandonXLF in topic Proposed merge
 | Text and/or other creative content from this version of Octopamine was copied or moved into Octopamine (drug) with this edit. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists. |
 | The contents of the Octopamine (drug) page were merged into Octopamine and it now redirects there. For the contribution history and old versions of the merged article please see its history. |
Note re provenance edit
I have created this article by separating out material from octopamine, which will shortly become a disambig page. The history of that article should be consulted for attribution of the material here. Looie496 (talk) 15:13, 14 December 2015 (UTC)
Proposed merge edit
- The following discussion is closed. Please do not modify it. Subsequent comments should be made in a new section. A summary of the conclusions reached follows.
- Merged.– BrandonXLF (talk) 20:08, 4 January 2020 (UTC)
Octopamine (drug) and Octopamine (neurotransmitter) are identical compounds, all the way down to IUPAC name and CAS number etc. The only possible difference is the chiral centre on the alpha carbon, a topic which neither article addresses. This is a WP:CONTENTFORK and an unnecessary disambiguation. Narky Blert (talk) 12:46, 7 September 2018 (UTC)
- On second thoughts, a better merge would be into p-octopamine. The DAB page octopamine is needed is distinguish between that compound and its isomer m-octopamine. Narky Blert (talk) 12:52, 7 September 2018 (UTC)
- I moved the proposed merge thread here from dab page to reflect recent page moves Coastside (talk) 14:46, 17 January 2019 (UTC)
- Support the merge of Octopamine (drug) and Octopamine (neurotransmitter). I don't agree that p-octopamine is a better name, as we should use the name a compound is best known by (WP:COMMONNAME), rather than one that it is chemically more precise. This is particularly important with the drug qualifier in the name; the INN is more appropriately used. This then raises the problem of the two-membered DAB page Octopamine. If these two pages are merged, then the DAB becomes redundant and we may as well (effectively) reverse the 2015 split. That split was done without discussion, and had a quite weak justification related to a technical problems with infoboxes; see Talk:Octopamine#Converted to disambig page. Thus, I suggest merging Octopamine (drug) and Octopamine (neurotransmitter) to Octopamine, and including a hatnote to norfenefrine (m-octopamine). Klbrain (talk) 09:15, 25 September 2019 (UTC)
Doing... – BrandonXLF (talk) 16:04, 4 January 2020 (UTC)
The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.